EnvisionChange | building leaders' skills and creating conversations for change | Believing we can do better—thought leader, change agent, innovator, strategist
With growing supply chain disruption in other industries with China trade due to coronavirus, what does this mean for API supply chain for pharmaceuticals?
API risk reportedbyNBC Nightly news. 98% of API produced in China (and India), we are at risk. If China cuts off trade on these vital product elements US hospitals would be incapacitated within 3 months. Outsourcing to achieve quarterly profits. Shameful.
2500 cases of Ebola. 1700 deaths. And despite a vaccine that appears effective. US took a critical role in marshaling global response before. The danger now is having no leader financing and driving immediate, massive response. https://t.co/RQ7INYzKt7
Partnership. Collaboration. Capacity building. Preparedness. Agile thinking. Sustainability. Speakers at the CGI Action Network conference are a unified front when it comes to the future of the Caribbean. #IdeasIntoAction@ClintonGlobal@ClintonFdn
So excited that my fav book The Art of Running in the Rain will be released as a movie in August with Kevin Costner as the voice of Enzo the dog sho is the story narrator. LOVE THIS STORYLINE.
The FDA lets companies report harm from some medical devices to a secret database rather than a public one. This is crazy (and a really good story from @KHNews@By_CJewett) https://t.co/q6NIfHivpf
Gottlieb will be missed: he has addressed critical issues such as shortages, increasing drug costs, generic drug development. See: @statnews Tweet this: Gottlieb’s leaving, and so is FDA’s highly effective communicator https://t.co/lWIjc7K4d7
Watching reports of drug pricing hearings, I look back on life experience of how willing co-conspirators — with the best of intentions — created downstream effect then unimaginable. EG: teaching PhRMA how to “use” PBMs. Until it flipped. Reflective lens perspective is harsh.